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Ribbing disease, a systematic review  
 
Abstract 
Background: Ribbing Disease, or Multiple Diaphyseal Sclerosis, is a rare benign bone 
dysplasia.  
Purpose: To systematically review the literature to determine the clinical and radiological  
presentation of patients with Ribbing Disease as well as the effects of attempted treatments. 
Material and Methods: We considered individual patient data of patients diagnosed with 
Ribbings Disease derived from patient reports and patient series. All stages of the review were 
performed by two reviewers independently. Standard descriptive statistics were used for 
quantitative analyses and mixed model analyses were used when appropriate 
Results: The literature search yielded 420 unique hits of which 23 studies were included, 
covering a total of 40 patients of whom 29 had bilateral involvement. The mean age at 
diagnosis was 35 years and the mean time between diagnosis and onset of symptoms, mostly 
pain, was 5 years ranging from 1 to 16 years. The tibial diaphysis was the most commonly 
involved bone in 35 of 36 patients. Non-surgical treatment consisted of Non-steroidal Anti-
Inflammatory Drugs (NSAIDs), prednisone and bisphophonates with mixed results. Surgical 
treatment consisted of intra-medullary reaming and fenestration and was very effective to 
reduce pain.  
Conclusion: The clinical presentation and imaging findings of patients with Ribbing Disease 
are becoming more apparent. However, there is paucity of evidence on the natural disease 
progression and effectiveness of treatment modalities.  
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Introduction 
Ribbing Disease, or Multiple Diaphyseal Sclerosis, is a rare benign bone dysplasia first 
described by Ribbing in 1949 (1). It is characterized by sclerosing bone lesions in the 
diaphyses of long bones in adult patients (1-4). The lower extremities are most often affected 
and the disease is usually asynchronous when multiple bones are involved. Some authors 
estimate that in the whole literature only 20 to 30 cases have been reported (3, 4). Since it's 
occurrence is so rare and due to lack of knowledge of this infrequent disease, the diagnosis is 
often delayed and may be mixed up with other sclerosing bone dysplasias, metabolic diseases 
or even osteomyelitis (3-5). Hence, most of the time Ribbing Disease is diagnosed by 
exclusion. Presently, no formal systematic review on Ribbing Disease exists. The purpose of 
this study was to systematically review the literature to determine the clinical and radiological  
presentation of patients with Ribbing Disease as well as the effects of attempted treatments.  
 
Material and Methods 
We performed a systematic review on individual patient data of patients diagnosed with 
Ribbings Disease (i.e. Multiple Diaphyseal Sclerosis) derived from patient reports and patient 
series. During all stages of the review process, a referee (PD), professor of orthopedic surgery 
with over 16 years of experience in musculoskeletal oncology, was available for consultation. 
The reporting of this systematic review is in accordance with the PRIMSA guidelines (6). 
 
Literature search 
A thorough literature search was performed together with a medical librarian (JS), 
experienced in the field of orthopedics, in order to increase the likelihood of retrieving all 
relevant studies (7). The following bibliographies were searched up to November 2015: 
Pubmed, MEDLINE, Embase, Web of Science, COCHRANE, CENTRAL, CINAHL, 
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Academic Search Premier, ScienceDirect, Wiley, LWW, HighWire, PubMedCentral, Google 
Scholar. References of included articles were screened for relevant studies. Articles in 
English, French, Italian, Spanish, Dutch and German were considered. The search strategy 
consisted of the following components, each defined by a combination of controlled 
vocabulary and free text terms:  
1) Ribbing Disease  
2) Multiple Diaphyseal Sclerosis. 
 
See appendix for more details on the strategy and terms. 
 
Inclusion and exclusion analysis 
Initial screening on the basis of title and abstract was performed by two reviewers 
independently and in duplicate (BS and KS) to identify studies of patients diagnosed with 
Ribbing Disease. When the information in the abstract did not suffice or when there was any 
doubt, the studies remained eligible. The full text of eligible studies was subsequently 
evaluated in duplicate by two reviewers (BP and KS) independently. Both recorded their 
findings in a pre-designed electronic database. Any disagreements were resolved by 
consensus or by consulting a referee. All bibliographic records identified through the 
electronic searches were collected in an electronic reference database and subjected to the 
following inclusion criteria: 
1) patient report or patient series of patients diagnosed with ribbing disease / multiple 
diaphyseal sclerosis 
2) clinical data on diagnosis or/and treatment 
 
Data extraction 
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Data were extracted independently by two reviewers (BP and KS) using a pre-defined 
electronic data collection sheet. Data consisted of study characteristics, patient demographics, 
diagnostic findings and clinical outcome. The data sheet was designed during the extraction of 
trial data on a random sample of eligible studies. Any disagreements were resolved by 
consensus or by consulting a referee. 
 
Data synthesis and analysis 
Since this systematic review deals with individual patient data from patient reports and patient 
series standard, descriptive statistics were used for quantitative analyses and mixed model 
analyses were used when appropriate (8). We checked for duplicate patients by comparing 
gender, age, bones effected, authors, country and treatment on a case by case bases. 
 
Results 
The literature search yielded 420 unique hits of which 23 studies were included, covering a 
total of 40 patients, 8 males and 32 females (Fig. 1, Suppl. Table 1) (1-4, 9-27). There were 
no duplicate patients identified. Nine studies originated from North America comprising 15 
patients (2, 9, 11, 19, 20, 22, 24, 25, 27). Seven studies originated from Asia, comprising 11 
patients (3, 10, 12-14, 21, 26). Six studies originated from Europe, comprising 13 patients (1, 
4, 15-18). One study originated from South America, comprising 1 patient (23). 
 
Clinical presentation 
In 30 of 33 patients pain (diaphyseal) was the presenting sign. Five of 8 patients also suffered 
from fatigability and 7 of 15 patients experienced muscle weakness The mean age at 
diagnosis was 35 years (SD 13 years). The mean age at which the symptoms began was 30 
years (SD 12 years). The mean time between diagnosis and onset of symptoms was 5 years 
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ranging from 1 to 16 years. For 27 patients the family history was reported. The family 
history was negative for (diaphyseal) musculoskeletal complaints or Ribbing Disease in 13 
patients and positive in 14 patients.   
 
Imaging 
X-ray examinations showed increased bone density (sclerosis) at the diaphysis with cortical 
endosteal and periosteal thickening (Figs. 2 and 3). In 25 patients a bone scan (Technetium 
99) was performed, which had an increased uptake in 24 patients and normal in one patient. In 
11 patients a CT scan was performed, which showed periosteal and endosteal thickening with 
narrowing of the intra-medullary canal (2, 3, 11, 12, 14, 16-18, 20, 27). In addition to the CT 
scans, in 13 patients MRI scans were performed, which showed endosteal marrow edema and 
no soft tissue involvement of the lesion (2, 4, 10-14, 17, 27). 
 
Laboratory findings 
In 17 patients laboratory findings of whole blood were reported. In 16 of 17 patients the ESR 
was normal. In 16 of 16 patients white blood cell count was normal. In 13 of 14 patients 
alkaline phosphatase was normal. Cultures of micro-organisms were negative in all reported 
cases except in one (25) where S. Epidermidis was grown and considered contamination 
because subsequent cultures were negative and no wound infection occurred (2, 3, 12, 15-17, 
19, 20, 25). 
 
Pathology 
In 24 cases histopathologic examinations were performed, which described osteosclerosis and 
foci with woven bone, mild osteitis, chronic osteoperiostitis, thickened trabeculae of lamellar 
bone with various sizes of the Haversian system, cortical thickening with fibrosis, new bone 
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formation with non-specific changes, new bone with unusually wide trabeculae and reactive 
cortical thickening (1-4, 9, 10, 12-17, 19, 20, 22, 25).  
 
Osseous involvement 
In all patients lesions were restricted to the diaphyses: there was no involvement of the 
metaphyses or epiphyses or progression to the metaphyses or epiphyses reported. In 29 of 37 
patients there was bilateral involvement of the bones. In 31 of 37 patients more than one bone 
was effected. In 30 of these 31 patients the stages of the disease were asynchronous. On 
average 2.8 bones were affected by the disease ranging from 1 to 8 bones. See Table 1 for a 
breakdown on anatomical location. The tibia was the most commonly involved bone with 35 
of 36 patients. The femur was the second most involved bone with 14 of 33 patients. The 
humerus was the least commonly involved bone with 2 of 28 patients. 
 
Treatment 
Non-surgical treatment consisted of Non-steroidal Anti-Inflammatory Drugs (NSAIDs), 
prednisone and bisphophonates. In 3 of 12 patients NSAIDs were effective. In 2 of 3 patients 
prednisone was effective. In 2 of 8 patients bisphophonates were effective. Surgical treatment 
consisted of intra-medullary reaming and fenestration. Four studies reported on intra-
medullary reaming, comprising four patients and five bones: four tibias and one femur (2, 3, 
15, 17). All the patients were pain free at last follow-up at mean of 3.4 years, ranging from 1 
to 5 years. One complication was reported of perforating the tibial cortex (false route from 
intra-medullary reaming), which was treated with 6 weeks non-weight bearing cast (2). Two 
studies reported on surgical fenestration, comprising 7 patients (12, 25). Seeger et al. reported 
on treatment of six patients with few details on anatomical location, outcome and follow-up 
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(25). Zhang et al. reported on one patient who underwent fenestration of the femur (12). This 
patient was pain free at 8 months’ follow-up. 
 
Exploratory analysis 
There were significantly more bones effected by the disease if the upper extremity was 
involved (4 vs 2.6 bones  p = 0.013). With the numbers available we found no associations 
between age, gender, time to diagnosis and total bones effected.  
 
Discussion 
The results of the systematic review showed that the characteristic patient with Ribbing 
disease is a 35 years old female with symptoms for 5 years including diaphyseal pain in the 
lower extremities. The X-rays show bilateral, asynchronous increased and typical sclerosis at 
the diaphysis with cortical endosteal and periosteal thickening of on average 2.8 bones. The 
bone scintigraphy has an increased uptake. ESR, whole blood count and alkaline phosphatase 
are within normal ranges. Cultures for micro-organisms are negative and histology has ruled 
out malignancy. 
The clinical presentation of Camurati-Engelmann disease resembles that of Ribbing disease 
(1, 3, 4). However, contrary to Ribbing disease, Camurati-Engelmann disease involves 
osteosclerosis of the skull base (56,5% of cases), the mandible (25% of cases), symmetry of 
bone involvement and the symptoms may start during childhood (1, 3, 4, 28). Unlike Ribbing 
disease, Camurati-Engelmann disease may show progression into the metaphyses (29). 
Camurati-Engelmann disease is associated with physical disability due to gait and 
neurological abnormalities (1, 3, 4).   Furthermore, Camurati-Engelmann is continuously 
progressive whereas Ribbing disease may become static (1, 3, 4). There seems to be some 
genetic overlap: Savoie et al. reported 2 patients with a known missense mutation in exon 2 of 
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TGFβ1 (4). This mutation has also been found in patients with Camurati-Engelmann (30). 
Makita et. al identified the Ribbing Disease phenotype in a 3-generation Japanese family with 
Camurati-Engelmann or progressive diaphyseal dysplasia and subsequently proposed that 
Camurati-Engelmann and Ribbing Disease represent phenotypic variation of the same 
disorder (21). 
There are also other differential diagnoses that should be considered, like, the group of 
sclerotic bone dysplasias that are more centered around the skull, but that may involve the 
peripheral skeleton (van Buchem’s disease, Worth disease, Nakamura disease, Truswell-
Hansen, Craniodiaphyseal dysplasia, Bakwin-Eiger syndrome), diaphyseal dysplasia with 
anemia (Ghosal hemato type), Gaffey disease, osteopetrosis group, overlap syndromes, 
multifocal periostitis, prostaglandin induced hyperostosis, Fluorosis, hypervitaminosis A, 
intra-medullary sclerosis, osteomyelitis, Chronic Recurrent Multifocal Osteomyelitis 
(CRMO), osteosarcoma, osteoid osteoma and stress fracture, among others (25). 
There is paucity of evidence regarding treatment. NSAIDs, prednisone, bisphophonates and 
surgical treatment all have been attempted with few data available for each treatment 
modality. Also there is the potential of publication bias and reporting bias as non-effective 
treatments may not be published or reported. It is therefore likely that the "effect" of the 
treatment is overestimated and that we are actually looking at the natural disease progress. 
Nevertheless, it appears that elevated intra-medullary pressure may contribute to the 
experience of pain since surgical relief of the pressure by either reaming or fenestration has an 
immediate effect on pain with dramatic reduction reported from visual analogue scale for pain 
(VAS) pre-operative of 9 to VAS post-operative of 0 (2, 15).  
The above clearly illustrates that more evidence is needed on the effectiveness of treatments 
for patients with Ribbing Disease. Improved reporting could be helpful by including pre-
intervention and post-intervention VAS pain scores. 
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Another area for improvement in treating patients with Ribbing Disease is reducing the time 
to diagnosis. Patients suffer from a long period of uncertainty as it takes a mean of 5 years 
from the onset of symptoms to make the diagnosis, and can even take 16 years in the most 
extreme case (4, 10, 12, 20). Delay in diagnosis in turn delays proper treatment which could 
affect quality of life. A bone scan is paramount to determine the number of affected bones and 
to determine the best location to obtain tissue samples and microbiological cultures to help 
differentiate between malignancy and osteomyelitis. 
The fact that there were significantly more bones affected by the disease if the upper 
extremity was involved suggests more advanced disease progression when the upper 
extremity is involved i.e. it starts with the lower extremities and may progress to the upper 
extremities. If a random distribution of the disease was assumed, then no difference between 
number of involved bones would have been found.  
We should consider some limitations. This review comprises 40 patients which a small 
number. Nevertheless, this number is significantly more than 20 to 30 cases as estimated by 
some recent studies (3,4). Also, publication bias and reporting bias could affect the findings 
particularly regarding treatment. 
In conclusion, the clinical presentation and imaging findings of patients with Ribbing Disease 
are becoming more apparent. However, there is paucity of evidence on the natural course of 
disease regarding the progression and effectiveness of treatment modalities. Future studies 
could therefore benefit from improved reporting with emphasis on treatment effects. 
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Study Year Country Age Gender Tibia Fibula Femur Humerus Radius Ulna Metatarsal Nr bones Treatment 
Ribbing 1949 Sweden 34 F 1 0 1 0 1 0  4  
Ribbing 1949 Sweden 30 M 1 0 0 0 0 0  1  
Ribbing 1949 Sweden 25 F 1 0 1 0 0 0  3  
Ribbing 1949 Sweden 20 F 1 1 0 0 0 0  3  
Lester 1953 US 20 M 1 1 1 0 1 0  6  
Lester 1953 US 35 M 1 0 1 0 0 1 0 4  
Favreau 1963 Canada 5 F 1 0 0 0 0 1  3  
Shier 1987 US 27 F 1 0 0 0 0 0 0 2  
Shier 1987 US 37 F 1 0 1 0 0 0  4  
Furia 1990 US 23 M 1 0 0 0 0 0  2  
Furia 1990 US 34 F 1 0 0 0 0 0  2  
Furia 1990 US 32 F 1 0 0 0 0 0  2  
Iwasaki 1991 Japan 52 F 1 0 0 0 0 0  1  
Seeger 1996 US 40 F 1 0 0 0 0 0  2 F 
Seeger 1996 US 39 F   1     2 F 
Seeger 1996 US 33 F 1       2 F 
Rubin 1997 Argentina 69 F 1 1 1 0 0 0 1 8 B 
Makita 2000 Japan 37 M          
Makita 2000 Japan 54 F 0 0 1 0 1 1  5  
Makita 2000 Japan 52 F          
Makita 2000 Japan 8 M 1 0 0 0 0 0  1  
Makita 2000 Japan 25 F          
Beals 2002 US 32 F 1  1     3 N; R 
Ziran 2002 US 39 M 1       2 B; N 
Dinges 2007 Germany 41 F 1 0 0 0 0 0  2  
Matas 2008 Spain 48 F 1 1 0 0 0 0  2 R 
Meyering 2008 US 46 F 1       1  
Gaeta 2009 Italie 35 F 1       2 N 
Mukkada 2010 India 37 F 1 0 0 0 0 0  2  
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Otten 2010 US 20 F 1 0 0 0 0 0  2 B; N 
Damle 2011 India 31 F 1 0 0 0 0 0  2 N 
Kang 2011 
South 
Korea 41 F 1 1 1 0 0 0  5  
Ozturkmen 2011 Turkey 22 F 1 0 0     1 R 
Zhang 2011 China 31 F 1  1     4 N; F 
Noain-
Sanz 2013 Spain 28 F 1 1 1     5 N; R 
Savoie 2013 France 65 M 1 0 0 0 1 0 0 3 B; N 
Savoie 2013 France 43 F 1 0 0 1 0 0 0 3 B; P; N 
Savoie 2013 France 52 F 1 0 1 0 0 0 0 4 B; P; N 
Savoie 2013 France 47 F 1 0 1 1 0 0 0 4 B; P; N 
Savoie 2013 France 26 F 1 0 0 0 0 0 0 1 B; N  
 
 
Table 1: details of included cases 
Regarding treatment: B = bisphophonates; P = prednisone; N = NSAIDs; R = Reaming (Surgical); F = Fenestration (Surgical). Bold indicates 
that the treatment was succesfull. Italic indicates that the treatment effect is unknown. 
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Figure Legends 
 
 
 
Fig. 1. Prisma flow chart 
 
Fig. 2. AP X-ray of lower leg, CT lower leg coronal image and MRI lower leg coronal images 
T1 and T2 showing typical presentation of Ribbing Disease. 
 
Fig. 3. Lateral X-ray of lower leg and CT lower leg axial image and MRI lower leg axial 
image showing typical presentation or Ribbing Disease.
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